NIH-Funded Study Indicates GLP-1 Treatment Extends Lifespan in Aged Mice

An NIH-funded study at UC Berkeley found that the GLP-1 drug semaglutide extended the lifespan of older, healthy mice. The treatment mitigated aging effects, in some cases surpassing benefits seen from calorie restriction. This research suggests GLP-1 agonists may slow physiological aging, potentially explaining their broad benefits in delaying age-related diseases and opening new avenues for anti-aging therapies.